Design Therapeutics, Inc. DSGN Issuance Costs Included In Accrued Expenses
Issuance Costs Included In Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept dsgn:IssuanceCostsIncludedInAccruedExpenses.
The official record: Design Therapeutics, Inc.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s issuance costs included in accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s issuance costs included in accrued expenses?
- Design Therapeutics, Inc. (DSGN) reported issuance costs included in accrued expenses of $4.25K in Q4 2025.
- What does issuance costs included in accrued expenses mean?
- This metric tracks costs related to the issuance of securities that have been incurred but not yet paid in cash, and are therefore recorded as accrued liabilities. It provides transparency into the total cost of capital-raising activities that have not yet impacted the company's cash position. Monitoring this is essential for understanding the full financial commitment associated with recent or pending financing rounds.